Диварасиб превзошел соторасиб и адаграсиб по общей выживаемости при KRAS G12C-мутантном раке легкого
Диварасиб превзошел соторасиб и адаграсиб по общей выживаемости при KRAS G12C-мутантном раке легкого the Pharma Media
Онкология
🎗️Лента новостей
Онкология
Study: Tucatinib substantially delays progression of breast cancer that has spread to the brain
Study: Tucatinib substantially delays progression of breast cancer that has spread to the brain Duke School of Medicine
Онкология
Combining 2 VEGF-Blocking Targeted Therapies Significantly Boosted Survival in Kidney Cancer Study
Combining 2 VEGF-Blocking Targeted Therapies Significantly Boosted Survival in Kidney Cancer Study Roswell Park Comprehensive Cancer Center
Онкология
ESMO26: US and FDA movements to improve oncology trials a positive signal
ESMO26: US and FDA movements to improve oncology trials a positive signal Clinical Trials Arena
Онкология
Savolitinib Plus Tagrisso Added About Five Months of Median Survival Over Chemo in MET-Driven Lung Cancer
Savolitinib Plus Tagrisso Added About Five Months of Median Survival Over Chemo in MET-Driven Lung Cancer Medical Daily
Онкология
Women’s Health Wednesday: New Breast Cancer Research at St. Peter’s Health Partners Reveals More Success with Tumor Removal
Women’s Health Wednesday: New Breast Cancer Research at St. Peter’s Health Partners Reveals More Success with Tumor Removal NEWS10 ABC
Онкология
Fighting cancer also means fighting against social stigma
Cancer-related discrimination arises from long-lasting cultural and institutional misconceptions, with significant impacts on every part of a person's quality of life and health—and Flinders University researchers say it requires coordinated policy, legal, institutional and public education responses for change to…
🎗️
Онкология
В Краснодаре открылся благотворительный центр помощи больным онкологией
В Краснодаре открылся благотворительный центр помощи больным онкологией Эксперт ЮГ
Онкология
Digital app significantly improves insomnia in women with cancer
More than 60% of women with cancer who completed a 6-week digital cognitive behavior therapy intervention had their insomnia cured at 24 weeks. Phase 3 randomized trial data, presented at the European Society for Medical Oncology Congress, show the guideline-recommended app Sleepio significantly improved insomnia…